Biological nanopores
Biological nanopores is part of the Nanopore Wiki learning path. Biological nanopores are protein or macromolecular pores that provide reproducible nanoscale sensing structures.
Core concepts
- Examples include alpha-hemolysin, MspA, CsgG, and engineered pore variants.
- Their defined structures enable precise sensing regions and mutation engineering.
- They often require membranes, suitable buffers, and careful protein handling.
- Commercial sequencing pores combine pore proteins with motors and integrated flow cells.
Scientific basis
- Examples include alpha-hemolysin, MspA, CsgG, and engineered pore variants.
- Their defined structures enable precise sensing regions and mutation engineering.
- Interpretations should be tied to measurable quantities, experimental controls, and documented analysis settings.
- Claims should distinguish direct observations from downstream inference.
Selection logic
| Step | Description |
|---|---|
| 1 | Define whether the target is DNA, RNA, protein, peptide, or small molecule. |
| 2 | Match pore constriction, charge environment, and stability to the target. |
| 3 | Check available mutations, adapters, or recognition sites. |
| 4 | Validate insertion, single-pore state, and target-specific events. |
Typical applications
- Nanopore sequencing.
- Single-molecule recognition and biosensing.
- Mechanistic studies of pore-analyte interactions.
Quality checks
- Record platform, pore or flow-cell type, chemistry, voltage or acquisition settings, and software versions.
- Use negative controls, positive controls, and replicate measurements where the claim depends on specificity.
- Report limitations such as noise, bias, sample degradation, pore instability, or model-dependent analysis.
- Separate physical mechanism, signal-processing choice, and biological interpretation.
Interpretation limits
- Assuming a pore optimized for sequencing is ideal for every sensing task.
- Ignoring protein storage, membrane composition, and insertion side.
- A single result should not be generalized beyond the sample, protocol, instrument state, and analysis pipeline used.
- Medical, legal, regulatory, or commercial decisions require domain-specific validation beyond this educational summary.